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Abstract 
7-N-Succinyldemethyllavendamycin esters-analogs of the naturally occurring, anti-tumor, 
anti-microbial agent lavendamycin-were synthesized by a six step pathway. These analogs 
were chosen for their possible biological activity and their solubility in pharmaceutical sol-
vents. NMR spectra, mass spectra, TLC, and melting point studies were performed on the 
final products and on each intermediate to verify structure and physical properties. 
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1 Background 
1.1 Lavendamycin 
1.1.1 Discovery and Activity 
In 1981, Doyle and associates reported the isolation ofthe compound known as lavendamycin 
. (2) from a fermentation broth of Streptomyces lavendulae at Bristol Laboratories [6],[1]. The 
purified product was a dark red solid, mp > 3000 dec. The compound exhibited very limited 
solubility in organic solvents. Consequently, an x-ray analysis was not possible. Through 
the use of UV spectroscopy, elemental analysis, mass spectroscopy, and NMR spectroscopy, 
the structure shown in figure 1 was determined. Lavendamycin (2) is closely related to 
0 
H3CO 0 
COOH 
H2N 
0 
CH3 0 
Figure 1: Streptonigrin and Lavendamycin 
streptonigrin (1) in structure and activity (figure 1). The reported isolation procedure for 
2 was significantly complex and yielded only a small amount of crude product. Over 3000 
liters of growth medium and bacteria were incubated for 170 hours. After extraction and 
several washings, 135 grams of crude product was isolated. Biological assays showed that 
lavendamycin demonstrated antimicrobial activity similar to streptonigrin but less potent. 
In addition, lavendamycin showed slight activity against a type of leukemia in mice. 
1.1.2 Total Synthesis 
After the discovery of lavendamycin by Doyle's group, several groups began attempts at 
total synthesis. The total synthesis of lavendamycin methyl ester was first published by 
Kende's group at the University of Rochester in 1984 [8], [9]. Their synthesis was composed 
of two key elements: a Friedlander condensation to synthesize the A and B rings of the 
final product, and a Bischler-Napieralski cyclodehydration to produce the skeleton of the 
pentacyclic product. 
The next group to achieve the total synthesis of lavendamycin methyl ester was the 
Hibino group. In contrast to Kende's group, Hibino used a Pictet-Spengler condensation 
1 
between .a-methyl tryptophan methyl ester and an analog of quinoline [7]. Following the 
condensation, the additional functionality to the A ring. At the same time, several other 
groups were also continuing research with similar goals [4], [11]. 
Behforouz's group decided to take up this research using a slightly different approach. 
They would ultimately use the Pictet-Spengler condensation to form the full five-ring laven-
damycin, but the intermediate quinoline ring was synthesized via a Diels-Alder conden-
sation [3]. Additionally, the quinoline ring system was completely functionallized before 
entering the Pictet-Spengler condensation. This method rivaled previous syntheses in effi-
ciency, conciseness, and practicality. Since then, Behforouz's group has developed an even 
more efficient pathway for the synthesis of the quinoline moiety (7) (figure 2 on the following 
page). 
1.2 7-N -Acetyllavendamycin Esters 
During the lavendamycin research, it was discovered that the 7-N-acyllavendamycin inter-
mediate (9) was a more selective antitumor agent than 2 itself. This discovery prompted 
Behforouz's group to begin an in depth study of other lavendamycin analogs [2J. This was 
for two reasons. First, it was hoped that further activity increases would arise when other 
analogs were synthesized. Second, it was hoped that an in depth study of analogs and their 
activity would provide some insight into the mechanism by which 2 and its analogs func-
tion. Only through a complete structure-activity relationship study (SAR), could the active 
subunits of 2 be determined. The novel research discussed in this paper is a part of this 
ongoing study. 
1.2.1 Total Synthesis 
The central feature of the efficient synthesis used by Behforouz's group is the Pictet-Spengler 
condensation shown in figure 3 on page 4. By carefully choosing different tryptophan and 
quinoline components, a large number of lavendamycin analogs with a variety of functional 
characteristics can be synthesized. The following section discusses some of the results from 
biological testing of such compounds. These results appear to be quite promising. 
1.2.2 Biological Activity 
Since the start of the project, Behforouz's group has synthesized many different analogs of 
2. Of these, several have shown excellent biological activity [2J. Specifically, acetyl analogs 
of 2 with methyl, i-amyl, and n-octyl esters showed 9-, 20-, and 130- fold selectivity against 
ras
K transformed cells. This is extraordinary when compared with lavendamycin's 0.5 fold 
selectivity against the same cells. 
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Figure 2: Total Synthesis of Lavendamycin Methyl Ester 
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Figure 3: Synthesis of Lavendamycin Analogs 
2 7-N -Succinyldemethyllavendamycin Esters 
The novel research discussed in this paper deals with succinyl analogs of 2. Those are 
analogs in which Rl = NHCO(CH2hC02H. This class of analogs was specifically chosen for 
two reasons. First, it is hoped that analogs of this type will exhibit even higher selective 
activity as anti-tumor agents. Second, it is hoped that the carboxyl group on the A ring of 
the lavendamycin will increase the solubility in polar solvents like water. This is because one 
of the main problems with the previous active analogs was their low solubility in common 
pharmaceutical solvents. Succinyl analogs may remedy that problem. 
2.1 Total Synthesis 
The overall pathway to the total synthesis of 7-N -succinyldemethyllavendamycin esters is 
similar to the pathway for lavendamycin methyl ester shown in figure 2 on the preceding 
page with a few changes. The first step is a double nitration of 8-hydroxyquinaldine (3), 
a commercially available compound. Next, the aromatic nitro groups on 4 are reduced 
to amino groups and complexed with hydrogen chloride via a hydrogenation. Third, the 
5,7-diamino-B-hydroxy-2-methylquinoline dihydrochloride salt (10) is reacted with succinic 
anhydride to form a disuccinamido quinoline (11). Fourth, 11 is oxidized with K2Cr207 to 
the quinoline dione (12). Next, the methyl side chain of 12 is oxidized to an aldehyde with 
selenium dioxide. Finally, this aldehyde (13) is condescend with a tryptophan ester to form 
the lavendamycin analogs. 
The complete pathway is shown in figure 4 on the next page. Differences between this 
pathway and the original synthesis of lavendamycin include substituting succinic anhydride 
for acetic anhydride in the acylation step. Additionally, the hydrogenation and Succinylation 
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Figure 4: Total synthesis of 7-N-Succinyldemethyllavendamycin 
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are performed separately unlike in the synthesis of 2. This change was made because the 
succinylation must be performed in a different solvent than the hydrogenation. This requires 
that the intermediate be isolated. In the original pathway, the two steps were done one after 
the other in the same reaction flask. 
During this research, two different 7-N -succinyldemethyllavendamycin esters were syn-
thesized. First, 7-N-succinyldemethyllavendamycin i-amyl ester (16) was synthesized using 
13 and tryptophan i-amyl ester. The tryptophan ester (14) in this case is not commercially 
available. It was synthesized via a standard Fischer esterification. The second analog syn-
thesized was 7-N-succinyldemethyllavendamycin n-butyl ester (17). The tryptophan ester 
for this condensation is available from Aldrich in the form of a hydrochloride salt. 
The two lavendamycin analogs and their intermediates were characterized using a variety 
of methods such as 1 H NMR, 13C NMR, thin layer chromatography, and mass spectroscopy. 
Each intermediate demonstrated characteristics that agree with expectations. Biological 
testing of these compounds will take place in the future. 
2.2 Selected Mechanisms 
In this section, several of the reactions of the overall pathway will be discussed. The reaction 
that will not be discussed is the oxidation of 8-hydroxy-2-methyl-5,7-disuccinamidoquinoline 
by K2Cr207. That mechanism is not fully understood by the chemical community at this 
time. Other mechanisms come from standard organic textbooks, chemical literature, and 
the mind's of the author and other Ball State students. 
2.2.1 Nitration of 8-Hydroxyquinaldine 
The nitration of 8-hydroxyquinaldine with HN03 and H2S04 is a very standard reaction. 
The mechanism consists of two electophilic attacks on the aromatic ring by NOt (figure 5 
on the following page). The first step in this mechanism is the protonation of nitric acid 
by sulfuric acid. Next, the protonated nitric acid loses water to form the nitronium cation. 
Electrophilic attack on the activated para- position followed by abstraction of a proton yields 
the singley substituted quinaldine. A second attack at the ortho- position yields the final 
product. 
The attacks occur at the ortho- and para- positions because of the resonance electron 
donating effect of the hydroxyl group at position 8. Figure 6 on the next page shows the 
resonance structures of 8-hydroxyquinaldine. It is because the second and third cannoical 
forms have negative charges at the ortho- and para- positions that electrophilic attack is 
favored there. Once the first nitro group attaches to the aromatic ring, its meta- directing, 
combined with the ortho-, para- directing of the hydroxyl group, guides the second nitro 
group to the 7 position. 
The pyridine ring is not nitrated in this case because of the electron withdrawing effect 
of the nitrogen atom. The electron density of the pyridine ring is significantly reduced 
6 
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Figure 5: The mechanism of the nitration of 3 
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Figure 6: Activity of the quinaldine ring 
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-and the ring has very low reactivity towards electrophilic attack. Additionally, the electron 
withdrawing of the nitrogen atom positively polarizes the pyridine ring further lowering its 
reactivity towards electrophiles. Figure 6 (b) shows this polarization [10]. 
2.2.2 Hydrogenation of 8-Hydroxy-2-methyl-5,7-dinitroquinoline 
The reduction of 8-hydroxy-2-methyl-5, 7-dinitroquinoline to 5,7-diamino-8-hydroxy-2-methyl-
quinoline dihydrochloride salt is accomplished by reaction with hydrogen gas in the presence 
of palladium charcoal and acid. Figure 7 shows the mechanistic pathway. Each nitro group 
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Figure 7: Mechanism of the hydrogenation of 4 
is reduced in a similar manner. A nitrogen first abstracts a hydrogen atom from the surface 
of the catalyst. This leaves one oxygen bound to the surface of the catalyst. A hydrogen 
attacks this oxygenand frees it from the surface of the catalyst. Loss of a water, at this 
point, leaves NO. From here, addition of two more moles of hydrogen yields the free amine. 
Exactly which path the addition goes through is unknown. Finally, the free amino groups 
are protonated and complex with chloride ions in solution to produce 10. 
2.2.3 Succinylation of 5,7-Diamino-8-hydroxy-2-methylquinoline Dihydrochlo-
ride Salt 
The succinylation of 5,7-diamino-8-hydroxy-2-methylquinoline dihydrochloride salt is an-
other standard reaction. The reaction is an amine acylation by an acid anhydride. The 
reaction mechanism contains several tetrahedral carbon intermediates (figure 8 on the next 
page). The NaOAc's role in the mechanism is to deprotonate the ammonium ion in order 
to convert the dihydrochloride salt into the free amine. The Na2S03 has a dual role in the 
mechanism. Besides its function as a base in a similar manner as NaOAc, the Na2S03 serves 
as an anti-oxidant to protect the free amine from oxidation. The hydroxyl group at position 
8 
--
WN~(SU~ h /. (Succ)HN N CH3 
OR 
Figure 8: The mechanism of the succinylation of 10 
8 of the diamine may be converted to OR via a similar pathway, but this substitution does 
not effect the success of the next reaction. 
2.2.4 Oxidation of 2-Methyl-7-succinamidoquinoline-5,8-dione 
The oxidation of the methyl group of the 2-methyl-7-succinamidoquinoline-5,8-dione is an 
interesting reaction. The oxidizing reagent in the reaction is selenium dioxide. In 1960, 
Corey and associates studied the mechanism of oxidations similar to this one [5]. While 
their article mostly concerns the oxidation of methylenes to aldehydes in the presence of an 
0:" ketone, they also discuss to application of these reactions to the oxidation of methylated 
quinoline derivatives. The mechanism they proposed is shown in figure 9 on the following 
page. This reaction also produces water and elemental selenium as by products. 
2.2.5 Pictet-Spengler Condensation 
The Pictet-Spengler condensation is the key reaction in the total synthesis of 7-N-succinyl-
demethyllavendamycin. In 1978, the mechanism of this class of reactions was studied at the 
University of Wisconsin-Milwaukee [12]. That group proposed the existence of a spiroindole-
nine intermediate during the condensation. The mechanism for the condensation based on 
their proposal is shown in figure 10 on page 11. 
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2.3 Experimental Procedures 
2.3.1 General Information 
Reagents 8-Hydroxyquinaldine, succinic anhydride, selenium dioxide, and tryptophan n-
butyl ester ammonium chloride salt were purchased from the Aldrich Chemical Company. 
Tryptophan i-amyl ester was prepared previously by Nasrin Olang via the Fischer esterifi-
cation method. 
Solvents 1,4-Dioxane was dried and distilled before use. All other solvents were reagent 
grade but were not distilled. 
Melting Points Reported melting points were obtained on a Thomas-Hoover Capillary 
melting point apparatus and are uncorrected. 
NMR Spectra 1 Hand 13C NMR Spectra were obtained on a Varian Gemini 200 spec-
trometer in d - DMSO using the residual DMSO peak at 2.49 ppm as the standard. 
Low Resolution Mass Spectra Low resolution MS were obtained in house on an Extrel 
ELQ 400 quadrapole instrument using EI ionization. 
Thin Layer Chromatography TLC was used to determine qualitative purity of products 
and reaction completion. Eastman silica gel sheets with fluorescent indicator were used. 
2.3.2 8-Hydroxy-2-methyl-5,7-dinitroquinoline (4) 
To an ice-cooled erlenmeyer flask equipped with a magnetic stir bar was added HN03 
(210 mL) and H2S04 (90 mL). To this mixture, 8-hydroxyquinaldine (30.00 g, 0.188 mol) 
was added slowly. The reaction flask was cooled and stirred for 90 minutes and then added 
to 600 mL of ice water. The bright yellow precipitate was filtered and dried giving 35.37 g 
(75%) of product. IH NMR (d-DMSO) 02.95 (s, 3 H), 8.16 (d, J = 9.2 HZ, 1 H), 9.22 (s, 1 
H), 9.67 (d, J = 9.0 Hz, 1 H). 
2.3.3 5,7-Diamino-8-hydroxy-2-methylquinoline Dihydrochloride Salt (10) 
In a hydrogenation flask was placed crushed 8-hydroxy-2-methyl-5,7-dinitroquinoline (15.00 g, 
0.060 mol) mixed with Pd - C 5% (2.5 g). To this mixture was added water (225 mL) and 
concentrated HCI (25 mL). The reaction mixture was placed on a Paar Hydrogenator for 
18 hours with 38 psi of hydrogen gas. The reaction mixture was filtered, the solvent was 
removed from the filtrate, and the bright orange product was dried. The reaction produced 
12.05 g (76%) of product. 
12 
-2.3.4 8-Hydroxy-2-methyl-S, 7 -disuccinamidoquinoline (11) 
To 80mL of stirring DMF under argon was added NaOAc (2.00 g), Na2S03 (2.00 g), and 
5,7-diamino-8-hydroxy-2-methylquinoline dihydrochloride salt (1.00 g, 3.81 mmol). Succinic 
anhydride (3.05 g) in 30 mL of DMF was added drop-wise, and the reaction was stirred for 
18 hours. The reaction mixture was filtered. To the filtrate was added 3 mL of water. After 
·1 hour, CH2Ch (500 mL) was added. After 36 hours, the orange-brown precipitate (1.17 g, 
79%) was filtered and dried. IH NMR (d-DMSO) 8 2.56-2.76 (m, 11 H), 7.37 (d, J = 8.8 
Hz, 1 H), 8.07 (s, 1 H), 8.20 (d, J = 8.4 Hz, 1 H), 9.49 (s, 1 H), 9.76 (s, 1 H). ElMS (reI. 
intensity) M+ (3.8) (M - 18)+ (38.0) (M - 37)+ (17.4) (M - 91)+ (30.9) (M - 200)+ (100). 
2.3.5 2-Methyl-7-succinamidoquinoline-5,8-dione (12) 
To K2Cr207 (1.36 g) in water (18 mL) and glacial acetic acid (21 mL) was added 8-hydroxy-
2-methyl-5,7-disuccinamidoquinoline (0.68 g, 1.75 mmol). The reaction was stirred for 20 
hours. The reaction mixture was extracted 7 times with CH2Ch (420 mL). The extracts 
were combined and dried with anhydrous MgS04 . After filtering, removal of solvent from 
the filtrate gave 0.22g (44%) of yellow solid. IH NMR (d-DMSO) 8 2.56-2.90 (m, 7 H), 
7.71 (s, 1 H), 7.73 (d, J = 8.3 Hz, 1 H), 8.24 (d, J = 7.9 Hz, 1 H), 9.98 (s, 1 H). ElMS 
(reI. intensity) M+ (21.7) (M - 74)+ (12.3) (M - 98)+ (70.8) (M - 100)+ (86.5) (M - 127)+ 
(100). 
2.3.6 2-Formyl-7-succinamidoquinoline-5,8-dione (13) 
To 2-methyl-7-succinamidoquinoline-5,8-dione (225.1 mg, 0.781 mmol) was added dioxane 
(4.00 mL), water (0.10 mL), and Se02 (167.9 mg). The reaction was stirred and refluxed 
under argon at 115°C for 11 hours. The reaction was filtered and the filter cake was returned 
to the flask and refluxed with 5 mL more dioxane. This was repeated once more, and 
all filtrates were combined. Removal of the dioxane gave 130.0mg (55%) of yellow-orange 
product. IH NMR (d-DMSO) 82.88 (t, J = 6.1 Hz, 2 H), 2.53 (t, J = 6.1 Hz, 2 H), 7.81 
(s, 1 H), 8.29 (d, J = 7 Hz, 1 H), 8.55 (d, J = 6.8 Hz, 1 H), 10.16 (s, 1 H), 10.24 (s, 1 H). 
ElMS (rel.intensity) (M - 1)+ (4.0) (M - 16)+ (12.1) (M - 98)+ (81.0) (M - 100)+ (81.1) 
(M - 127)+ (60.8). 
2.3.7 Tryptophan n-Butyl Ester (IS) 
To 50 mL of ethyl acetate was added tryptophan n-butyl esterhydrochloride salt (334 mg, 
1.25 mmol). This mixture was stirred and 14% NH40H was added drop-wise until the 
solution reached pH 10. The solution was extracted 3 times with 30 mL of ethyl acetate 
and was dried with anhydrous MgS04• The mixture was filtered, and removal of the solvent 
gave 290 mg (97%) of light yellow oil. 
13 
-2.3.8 7-N -Succinyldemethyllavendamycin i-Amyl Ester (16) 
To 200 mg (0.662 mmol) of 2-formyl-7-succinamidoquinoline-5,8-dione under argon was 
added anisole (250 mL) and tryptophan i-amyl ester (218 mg, 0.798 mmol). The reac-
tion was stirred and reftuxed at 120°C for 11 hours. The reaction mixture was filtered, and 
the filtrate was concentrated until a red precipitate formed (31 mg, 8%). m.p. > 200° de-
composed. IH NMR (d-DMSO) 6 1.05 (d, J = 6.2 Hz, 6 H), 1.25 (m, 1 H), 1.76 (m, 2 H), 
2.60 (m, 2 H), 2.90 (m, 2 H), 4.46 (t, J = 6.7 Hz, 2 H), 7.44 (m, 1 H), 7.72 (m, 2 H), 7.81 
(s, 1 H), 8.59 (d, J = 6 Hz, 1 H), 8.56 (d, J = 8 Hz, 1 H), 8.91 (d, J = 8 Hz, 1 H), 9.10 (s, 
1 H), 10.36 (s, 1 H), 11.98 (s, 1 H). 
2.3.9 7-N -Succinyldemethyllavendamycin n-Butyl Ester (17) 
To 80 mg (0.265 mmol) of 2-formyl-7-succinamidoquinoline-5,8-dione under argon was added 
anisole (100 mL) and tryptophan n-butyl ester (79 mg, 0.305 mmol). The reaction was stirred 
and refluxed at 120°C for 9 hours. The reaction mixture was filtered, and the solvent was 
removed from the filtrate. The brown-red solid was recrystallized in ethyl acetate to give 
28 mg (20%) of an orange-red solid. IH NMR (d-DMSO) 6 1.04 (t, J = 7.2 Hz, 3 H), 1.55 
(m, 2 H), 1.84 (m, 2 H), 2.59 (t, 2 H), 2.93 (t, 2 H), 4.45 (t, J = 6.6 Hz, 2 H), 7.45 (m, 1 
H), 7.73 (m, 2 H), 7.82 (s, 1 H), 8.54 (d, J = 8 Hz, 1 H), 8.60 (d, J = 8.7 Hz, 1 H), 8.95 (d, 
J = 8.3 Hz, 1 H), 9.10 (s, 1 H), 10.29 (s, 1 H), 11.97 (s, 1 H). 
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Appendix A - lAS Presentation 
On November 3, 1995, the author went to the Indiana Academy of Science annual meeting. 
At that meeting, he gave a presentation of the material discussed in this paper to the members 
of the academy and to his peers. The experience was an important part of his education as 
presentations will undoubtedly be part of the requirements he will face in graduate school 
and in the work place. 
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Appendix B - Spectra 
The following spectra are included in this section: 
1. IH NMR spectrum of S-hydroxy-2-methyl-5,7-dinitroquinoline 
2. IH NMR spectrum of S-hydroxy-2-methyl-5,7-disuccinamidoquinoline 
3. IH NMR spectrum of 2-methyl-7-succinamidoquinoline-5,S-dione 
4. IH NMR spectrum of 2-formyl-7-succinamidoquinoline-5,S-dione 
5. IH NMR spectrum of 7-N-succinyldemethyllavendamycin i-amyl ester 
6. IH NMR spectrum of 7-N-succinyldemethyllavendamycin n-butyl ester 
7. Low Resolution MS of S-hydroxy-2-methyl-5,7-disuccinamidoquinoline 
S. Low Resolution MS of 2-methyl-7-succinamidoquinoline-5,S-dione 
9. Low Resolution MS of 2-formyl-7-succinamidoquinoline-5,S-dione 
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